Physician profile
Leonard Grecul
NPI 1164412284
$34,084.40
in general payments reported to CMS, 2019-2025
21 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $969 · 2021: $1,515 · 2022: $2,020 · 2023: $546 · 2024: $167 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $20,877.71 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,239.85 | 2019-2023 | Jardiance |
| Biotronik INC. | $726.69 | 2019-2024 | Amvia Edge |
| Boston Scientific Corporation | $681.89 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Watchman Flx |
| Abbott Laboratories | $477.05 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $384.42 | 2019-2022 | |
| Amgen INC. | $383.39 | 2019-2023 | Repatha |
| Medtronic, INC. | $342.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $298.08 | 2019-2025 | Eliquis |
| Pfizer INC. | $287.22 | 2019-2023 | |
| Medtronic Vascular, INC. | $285.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $213.49 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $173.17 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $141.84 | 2022-2023 | Verquvo |
| Irhythm Technologies, INC. | $131.57 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.85 | 2019-2022 | |
| Shockwave Medical, INC | $128.94 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.69 | 2021-2022 | |
| Cardiva Medical, INC. | $67.08 | 2019-2022 | |
| Esperion Therapeutics, INC. | $25.20 | 2021 | |
| Amarin Pharma, INC. | $19.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Grecul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.